Regeneron (REGN) Tops Q4 EPS by $2.39, Revenues Beat
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $803.48 -0.31%
Financial Fact:
Income tax benefit: -101.08M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Income tax benefit: -101.08M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Regeneron (NASDAQ: REGN) reported Q4 EPS of $12.56, $2.39 better than the analyst estimate of $10.17. Revenue for the quarter came in at $3.41 million versus the consensus estimate of $3.13 billion.
For earnings history and earnings-related data on Regeneron (REGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
